Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$668M |
| 2 |
Chevron
CVX
|
+$626M |
| 3 |
NVIDIA
NVDA
|
+$567M |
| 4 |
Microsoft
MSFT
|
+$538M |
| 5 |
CRH
CRH
|
+$534M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$599M |
| 2 |
Intel
INTC
|
+$509M |
| 3 |
Eli Lilly
LLY
|
+$240M |
| 4 |
Analog Devices
ADI
|
+$239M |
| 5 |
EOG Resources
EOG
|
+$203M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.7% |
| 2 | Healthcare | 13.61% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Financials | 10.25% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Matsons
MATX
$6.37B
| $399K | ﹤0.01% |
4,508
-99
| -2% | -$8.64K |
|
1352
Outset Medical
OM
$74.9M
| $398K | ﹤0.01% |
7,818
+375
| +5% | +$88.5K |
|
1353
American Eagle Outfitters
AEO
$2.85B
| $395K | ﹤0.01% |
23,466
+3
| +0% | +$44 |
|
1354
Signet Jewelers
SIG
$3.55B
| $393K | ﹤0.01% |
5,672
-105
| -2% | -$7.79K |
|
1355
Ginkgo Bioworks
DNA
$481M
| $389K | ﹤0.01% |
5,857
+1,093
| +23% | +$87.4K |
|
1356
New York Times
NYT
$11.6B
| $384K | ﹤0.01% |
+9,014
| New | +$379K |
|
|
TPIC
1357
DELISTED
TPI Composites
TPIC
| $384K | ﹤0.01% |
158,918
| – | – |
|
1358
LCI Industries
LCII
$2.51B
| $383K | ﹤0.01% |
3,404
-60
| -2% | -$7.52K |
|
|
WIRE
1359
DELISTED
Encore Wire Corp
WIRE
| $380K | ﹤0.01% |
2,134
-198
| -8% | -$33.6K |
|
1360
Prestige Consumer Healthcare
PBH
$2.35B
| $376K | ﹤0.01% |
6,324
+7
| +0.1% | +$423 |
|
|
NVEI
1361
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $376K | ﹤0.01% |
24,840
+1,670
| +7% | +$38.7K |
|
|
UCB
1362
United Community Banks
UCB
$4.22B
| $374K | ﹤0.01% |
15,027
+413
| +3% | +$11.2K |
|
1363
Liberty Media Series A
FWONA
$22.3B
| $374K | ﹤0.01% |
6,265
-75,229
| -92% | -$4.58M |
|
1364
Simply Good Foods
SMPL
$904M
| $374K | ﹤0.01% |
11,453
+701
| +7% | +$25.2K |
|
|
DISH
1365
DELISTED
DISH Network Corp.
DISH
| $371K | ﹤0.01% |
73,758
| – | – |
|
1366
ABM Industries
ABM
$2.8B
| $371K | ﹤0.01% |
8,426
-176
| -2% | -$7.62K |
|
1367
OSI Systems
OSIS
$3.57B
| $362K | ﹤0.01% |
3,089
-3
| -0.1% | -$362 |
|
|
FL
1368
DELISTED
Foot Locker
FL
| $360K | ﹤0.01% |
17,250
-1,442
| -8% | -$32.3K |
|
1369
Progress Software
PRGS
$1.55B
| $359K | ﹤0.01% |
6,852
+4
| +0.1% | +$234 |
|
1370
DocGo
DCGO
$58.9M
| $358K | ﹤0.01% |
61,139
+23,145
| +61% | +$188K |
|
1371
Steven Madden
SHOO
$3.12B
| $358K | ﹤0.01% |
11,202
| – | – |
|
1372
AMN Healthcare
AMN
$1.28B
| $356K | ﹤0.01% |
4,822
-438
| -8% | -$41.5K |
|
|
VISN
1373
Vistance Networks Inc
VISN
$2.66B
| $354K | ﹤0.01% |
150,169
+4,306
| +3% | +$17.6K |
|
1374
Genworth Financial
GNW
$3.8B
| $353K | ﹤0.01% |
58,718
-2,866
| -5% | -$16.5K |
|
|
HI
1375
DELISTED
Hillenbrand
HI
| $352K | ﹤0.01% |
8,839
+16
| +0.2% | +$761 |
|
Similar funds
Amundi's Q3 2023 Portfolio in Review
As of Q3 2023, Amundi held 2,094 positions worth $203B, up 2.9% from $198B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Amundi deployed $11.1B of net new capital in Q3 2023, opening 69 new positions and adding to 881 existing holdings. Its largest new stake was Kenvue: 14,174,156 shares worth $275M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $599M trimmed.
- Amundi's largest Q3 2023 buy was Kenvue: 14,174,156 shares worth $275M.
- Amundi added most to UnitedHealth in Q3 2023, an estimated $668M increase.
- Amundi's biggest Q3 2023 reduction was Advanced Micro Devices, cutting an estimated $599M.
- Amundi fully exited Elanco Animal Health in Q3 2023, selling an estimated $25.3M.
- Amundi's ten largest holdings make up 23% of its $203B portfolio in Q3 2023.
- Amundi opened 69 new positions and closed 87 in Q3 2023.
- Amundi's portfolio value rose 2.9% quarter-over-quarter to $203B.
Based on Amundi's 13F filing for Q3 2023, filed 14 Nov 2023.